Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: Inhibition by sodium nitroprusside

85Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

We studied 11 patients with congestive heart failure and 10 normal volunteers for in vivo platelet aggregate formation activity. The patients with heart failure had significantly (p<0.01) more circulating platelet aggregates than the normal volunteers. During sodium nitroprusside infusion, the number of circulating platelet aggregates declined to normal levels and in vitro platelet aggregation responses to epinephrine and adenosine diphosphate were also suppressed significantly (p<0.01). This was associated with a 30% decline in systemic vascular resistance and a 28% increase in cardiac output. In other in vitro experiments, sodium nitroprusside was found to have direct, dose-related platelet aggregation inhibitory actions. This study suggests that an increase in vascular resistance in certain heart failure patients may in part be related to an increase in circulating platelet aggregates. Direct inhibition of platelet aggregation by sodium nitroprusside may be a mechanism of its beneficial effects in heart failure.

Cite

CITATION STYLE

APA

Mehta, J., & Mehta, P. (1979). Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: Inhibition by sodium nitroprusside. Circulation, 60(3), 497–503. https://doi.org/10.1161/01.CIR.60.3.497

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free